.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Odisha government recently took decisive action regarding Odisha health scheme violations. Health Minister Mukesh Mahaling announced the de-rostering of 10 private hospitals from the Ayushman Bharat-Gopabandhu Jana Arogya Yojana (AB-GJAY). Furthermore, authorities penalised another facility in Ganjam for submitting duplicate claims. This move highlights the state's commitment to maintaining strict oversight of healthcare providers. Consequently, these measures aim to protect the integrity of cashless healthcare benefits for eligible citizens.
Government officials examined 56 specific complaints concerning irregularities by empanelled hospitals. Following a formal review, they issued show-cause notices to several facilities. Consequently, ten hospitals faced suspension while one hospital received a financial penalty. These facilities operate in multiple districts, including Cuttack, Ganjam, and Khurda. Specifically, the government acted against violations such as negligence, lack of proper clinical registration, and scheme guideline breaches. One case even involved the tragic death of a woman, prompting immediate administrative intervention.
Minister Mahaling emphasised that the government is closely monitoring all healthcare providers under the scheme. This oversight ensures that beneficiaries receive high-quality, cashless treatment as promised. Additionally, the government recovered a penalty of Rs 58,500 from a hospital in Ganjam for duplicate claim submissions. The health department continues to initiate proceedings whenever it receives valid complaints. Therefore, hospitals must adhere strictly to established norms to avoid show-cause proceedings. These efforts strengthen the Ayushman Bharat-Gopabandhu Jana Arogya Yojana's ability to serve the public effectively across Odisha.
Q1: Why were the ten private hospitals suspended in Odisha?
The hospitals faced suspension due to irregularities, violation of scheme norms, lack of valid clinical establishment registrations, and negligence in patient care.
Q2: What is the primary goal of the Ayushman Bharat-Gopabandhu Jana Arogya Yojana?
The scheme provides cashless healthcare benefits to eligible beneficiaries throughout Odisha, ensuring access to high-quality medical treatment without financial burden.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Odisha government has de-rostered 10 private hospitals and penalised another for violating Ayushman Bharat-Gopabandhu Jana Arogya Yojana guidelines....
6 months ago
A breakthrough peer-reviewed study demonstrates that a sequential AI diagnosis system can mirror real-world clinical reasoning. By ordering stepwise tests and updating hypotheses dynamically, this multi-agent orchestrator achieved superior diagnostic accuracy while reducing investigative costs.
Today
A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
